Nomura Holdings Inc. lowered its stake in shares of Waters Co. (NYSE:WAT) by 27.3% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,090 shares of the medical instruments supplier’s stock after selling 2,285 shares during the quarter. Nomura Holdings Inc.’s holdings in Waters were worth $1,179,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently modified their holdings of the company. WP Advisors LLC acquired a new stake in Waters in the second quarter worth about $101,000. Summit Trail Advisors LLC boosted its holdings in Waters by 68,148.5% in the first quarter. Summit Trail Advisors LLC now owns 113,975 shares of the medical instruments supplier’s stock worth $114,000 after acquiring an additional 113,808 shares in the last quarter. Fort L.P. acquired a new stake in Waters in the second quarter worth about $118,000. Cornerstone Advisors Inc. boosted its holdings in Waters by 1,651.2% in the second quarter. Cornerstone Advisors Inc. now owns 753 shares of the medical instruments supplier’s stock worth $146,000 after acquiring an additional 710 shares in the last quarter. Finally, Ledyard National Bank boosted its holdings in Waters by 300.0% in the second quarter. Ledyard National Bank now owns 1,200 shares of the medical instruments supplier’s stock worth $232,000 after acquiring an additional 900 shares in the last quarter. 99.27% of the stock is currently owned by institutional investors.

Shares of NYSE:WAT opened at $196.76 on Monday. Waters Co. has a 52-week low of $177.58 and a 52-week high of $220.20. The stock has a market capitalization of $15.16 billion, a PE ratio of 26.27, a PEG ratio of 2.41 and a beta of 0.96. The company has a debt-to-equity ratio of 0.58, a current ratio of 6.58 and a quick ratio of 5.95.

Waters (NYSE:WAT) last announced its quarterly earnings data on Tuesday, July 24th. The medical instruments supplier reported $1.95 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.92 by $0.03. Waters had a return on equity of 27.85% and a net margin of 2.12%. The firm had revenue of $596.20 million during the quarter, compared to analysts’ expectations of $598.73 million. During the same period last year, the business posted $1.76 earnings per share. The company’s revenue for the quarter was up 6.8% compared to the same quarter last year. equities analysts predict that Waters Co. will post 8.11 earnings per share for the current fiscal year.

WAT has been the subject of several recent analyst reports. Zacks Investment Research raised Waters from a “sell” rating to a “hold” rating in a report on Thursday, August 23rd. Janney Montgomery Scott downgraded Waters from a “buy” rating to a “neutral” rating and lowered their price target for the stock from $230.00 to $211.00 in a report on Tuesday, July 17th. Bank of America downgraded Waters from a “neutral” rating to an “underperform” rating and set a $190.00 price target for the company. in a report on Monday, July 16th. Morgan Stanley lowered their price target on Waters from $205.00 to $204.00 and set an “equal weight” rating for the company in a report on Wednesday, July 25th. Finally, Cleveland Research downgraded Waters from a “neutral” rating to an “underperform” rating in a report on Thursday, June 14th. Two analysts have rated the stock with a sell rating, twelve have issued a hold rating and four have given a buy rating to the company. The company currently has a consensus rating of “Hold” and an average price target of $206.27.

In other news, SVP Elizabeth B. Rae sold 4,000 shares of the firm’s stock in a transaction dated Monday, August 27th. The stock was sold at an average price of $190.62, for a total value of $762,480.00. Following the completion of the transaction, the senior vice president now directly owns 9,443 shares in the company, valued at $1,800,024.66. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 0.98% of the company’s stock.

Waters Company Profile

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in the United States, Europe, Asia, and internationally. It designs, manufactures, sells, and services high and ultra performance liquid chromatography technology, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Recommended Story: Fundamental Analysis and Choosing Stocks

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.